Amedeo Smart

Free Medical Literature Service


 

Amedeo

Malaria

  Free Subscription

Articles published in
Clin Infect Dis
    September 2022
  1. WHALEN ME, Kajubi R, Goodwin J, Orukan F, et al
    The impact of extended treatment with artemether-lumefantrine on antimalarial exposure and reinfection risks in Ugandan children with uncomplicated malaria: A randomized controlled trial.
    Clin Infect Dis. 2022 Sep 20. pii: 6708265. doi: 10.1093.
    >> Share

  2. THOMAS CM, Stauffer WM, Alpern JD
    FDA Approval of Artesunate for Severe Malaria-Enough to Achieve Best Practice?
    Clin Infect Dis. 2022 Sep 3. pii: 6691362. doi: 10.1093.
    >> Share

  3. ABANYIE F, Ng J, Tan KR
    Post-Artesunate Delayed Hemolysis in Patients with Severe Malaria in the United States-April 2019 Through July 2021.
    Clin Infect Dis. 2022 Sep 2. pii: 6686391. doi: 10.1093.
    >> Share

    August 2022
  4. HUGHES E, Wallender E, Kajubi R, Jagannathan P, et al
    Piperaquine-Induced QTc Prolongation Decreases With Repeated Monthly Dihydroartemisinin-Piperaquine Dosing in Pregnant Ugandan Women.
    Clin Infect Dis. 2022;75:406-415.
    >> Share

    July 2022
  5. LI Y, Stewart K, Han KT, Han ZY, et al
    Understanding spatio-temporal human mobility patterns for malaria control using a multi-agent mobility simulation model.
    Clin Infect Dis. 2022 Jul 19. pii: 6646427. doi: 10.1093.
    >> Share

    June 2022
  6. ANDAGALU B, Watson OJ, Onyango I, Opot B, et al
    Malaria Transmission Dynamics in High Transmission Setting of Western Kenya and the Inadequate Treatment Response to Artemether-lumefantrine in an Asymptomatic Population.
    Clin Infect Dis. 2022 Jun 29. pii: 6619621. doi: 10.1093.
    >> Share

  7. KAMAU A, Musau M, Mwakio S, Amadi D, et al
    The impact of intermittent presumptive treatment for malaria in pregnancy on hospital birth outcomes on the Kenyan coast.
    Clin Infect Dis. 2022 Jun 22. pii: 6613334. doi: 10.1093.
    >> Share

  8. STEFANOVA V, Ngai M, Weckman AM, Wright JK, et al
    suPAR as a Prognostic Marker of Ugandan Children at Risk of Severe and Fatal Malaria.
    Clin Infect Dis. 2022 Jun 8. pii: 6604399. doi: 10.1093.
    >> Share

    May 2022
  9. HAUSER M, Kabuya JB, Mantus M, Kamavu LK, et al
    Malaria in Refugee Children Resettled to a Holoendemic Area of Sub-Saharan Africa.
    Clin Infect Dis. 2022 May 31. pii: 6595698. doi: 10.1093.
    >> Share

  10. ISHOLA D
    Asymptomatic Malaria Infection and the Immune Response to the 2-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children.
    Clin Infect Dis. 2022 May 30. pii: 6595436. doi: 10.1093.
    >> Share

  11. KAMAU E, Chaudhury S, Bolton JS, Slike BM, et al
    Susceptibility to HIV-1 Acquisition linked to Malaria Exposure: A Case-control Study.
    Clin Infect Dis. 2022 May 20. pii: 6589785. doi: 10.1093.
    >> Share

    April 2022
  12. NIANG M, Sandfort M, Mbodj AF, Diouf B, et al
    Correction to: Fine-scale Spatiotemporal Mapping of Asymptomatic and Clinical Plasmodium falciparum Infections: Epidemiological Evidence for Targeted Malaria Elimination Interventions.
    Clin Infect Dis. 2022 Apr 26. pii: 6574503. doi: 10.1093.
    >> Share

    March 2022
  13. NAMAZZI R, Opoka R, Datta D, Bangirana P, et al
    Acute kidney injury interacts with coma, acidosis, and impaired perfusion to significantly increase risk of death in children with severe malaria.
    Clin Infect Dis. 2022 Mar 29. pii: 6555660. doi: 10.1093.
    >> Share

    February 2022
  14. COPPEE R, Bailly J, Sarrasin V, Vianou B, et al
    Circulation of an artemisinin-resistant malaria lineage in a traveller returning from East Africa to France.
    Clin Infect Dis. 2022 Feb 25. pii: 6537062. doi: 10.1093.
    >> Share

  15. COOPER DJ, Grigg MJ, Plewes K, Rajahram GS, et al
    The effect of regularly dosed acetaminophen versus no acetaminophen on renal function in Plasmodium knowlesi malaria (PACKNOW): a randomised controlled trial.
    Clin Infect Dis. 2022 Feb 18. pii: 6532035. doi: 10.1093.
    >> Share

    January 2022
  16. WHITE NJ, Watson JA, Simpson JA
    Severe malaria, Pascalian therapeutics and the US FDA.
    Clin Infect Dis. 2022 Jan 12. pii: 6505266. doi: 10.1093.
    >> Share

    December 2021
  17. PUTAPORNTIP C, Kuamsab N, Seethamchai S, Pattanawong U, et al
    Cryptic Plasmodium inui and P. fieldi infections among symptomatic malaria patients in Thailand.
    Clin Infect Dis. 2021 Dec 31. pii: 6491219. doi: 10.1093/cid/ciab1060.
    >> Share

  18. MOHANTY S, Sahu PK, Pattnaik R, Majhi M, et al
    Evidence of Brain Alterations in Noncerebral Falciparum Malaria.
    Clin Infect Dis. 2021 Dec 15. pii: 6460593. doi: 10.1093.
    >> Share

  19. SAGARA I, Zongo I, Cairns M, Yerbanga RS, et al
    The Anti-Circumsporozoite Antibody Response Of Children To Seasonal Vaccination With The Rts,S/As01e Malaria Vaccine.
    Clin Infect Dis. 2021 Dec 11. pii: 6459764. doi: 10.1093/cid/ciab1017.
    >> Share

    November 2021
  20. ADJEI GO, Sulley AM, Goka BQ, Enweronu-Laryea C, et al
    Performance of an HRP-2 based (First Response(R)) and p-LDH-based (Optimal(R)) rapid diagnostic tests for diagnosis of malaria in paediatric sickle cell disease patients.
    Clin Infect Dis. 2021 Nov 26. pii: 6440806. doi: 10.1093.
    >> Share

    October 2021
  21. YERLIKAYA S, Owusu EDA, Frimpong A, DeLisle RK, et al
    A Dual, Systematic Approach to Malaria Diagnostic Biomarker Discovery.
    Clin Infect Dis. 2021 Oct 28. pii: 6413623. doi: 10.1093.
    >> Share

  22. HOOFT AM, Ndenga B, Mutuku F, Otuka V, et al
    High Frequency of Antibiotic Prescription in Children With Undifferentiated Febrile Illness in Kenya.
    Clin Infect Dis. 2021;73:e2399-e2406.
    >> Share

    September 2021
  23. BOYCE RM, Hollingsworth BD, Baguma E, Xu E, et al
    Dihydroartemisinin-piperaquine chemoprevention and malaria incidence after severe flooding: evaluation of a pragmatic intervention in rural Uganda.
    Clin Infect Dis. 2021 Sep 9. pii: 6367762. doi: 10.1093.
    >> Share

    August 2021
  24. SCHMITT EK, Ndayisaba G, Yeka A, Asante KP, et al
    Efficacy of cipargamin (KAE609) in a randomized, Phase II dose-escalation study in adults in sub-Saharan Africa with uncomplicated Plasmodium falciparum malaria.
    Clin Infect Dis. 2021 Aug 19. pii: 6354946. doi: 10.1093.
    >> Share

  25. LEWIS JM, Mphasa M, Keyala L, Banda R, et al
    A longitudinal observational study of aetiology and long-term outcomes of sepsis in Malawi revealing the key role of disseminated tuberculosis.
    Clin Infect Dis. 2021 Aug 18. pii: 6354427. doi: 10.1093.
    >> Share

    July 2021
  26. ABANYIE F, Acharya SD, Leavy I, Bowe M, et al
    Safety and Effectiveness of Intravenous Artesunate for Treatment of Severe Malaria in the United States -April 2019 through December 2020.
    Clin Infect Dis. 2021 Jul 27. pii: 6329244. doi: 10.1093.
    >> Share

  27. GARRISON A, Boivin MJ, Fievet N, Zoumenou R, et al
    The effects of malaria in pregnancy on neurocognitive development in children at one and six years of age in Benin: a prospective mother-child cohort.
    Clin Infect Dis. 2021 Jul 23. pii: 6326477. doi: 10.1093.
    >> Share

  28. WANGDAHL A, Sonden K, Wyss K, Stenstrom C, et al
    Relapse of Plasmodium vivax and Plasmodium ovale malaria with and without primaquine treatment in a non-endemic area.
    Clin Infect Dis. 2021 Jul 3. pii: 6314296. doi: 10.1093.
    >> Share

    May 2021
  29. DABIRA ED, Hachizovu S, Conteh B, Mendy A, et al
    Efficacy, Safety and Tolerability of Pyronaridine-artesunate in Asymptomatic Malaria-infected Individuals: a Randomized Controlled Trial.
    Clin Infect Dis. 2021 May 13. pii: 6275208. doi: 10.1093.
    >> Share

    April 2021
  30. SUMNER KM, Freedman E, Mangeni JN, Obala AA, et al
    Exposure to diverse Plasmodium falciparum genotypes shapes the risk of symptomatic malaria in incident and persistent infections: A longitudinal molecular epidemiologic study in Kenya.
    Clin Infect Dis. 2021 Apr 27. pii: 6255633. doi: 10.1093.
    >> Share

  31. MAHAMAR A, Andemel N, Swihart B, Sidibe Y, et al
    Malaria infection is common and associated with perinatal mortality and preterm delivery despite widespread use of chemoprevention in Mali: an observational study 2010 to 2014.
    Clin Infect Dis. 2021 Apr 13. pii: 6224393. doi: 10.1093.
    >> Share

    March 2021
  32. ZEHNER N, Adrama H, Kakuru A, Andra T, et al
    Age-related Changes in Malaria Clinical Phenotypes During Infancy are Modified by Sickle Cell Trait.
    Clin Infect Dis. 2021 Mar 19. pii: 6178468. doi: 10.1093.
    >> Share

  33. KAMALIDDIN C, Sutherland CJ, Houze S, Cottrell G, et al
    The role of ultra-sensitive molecular methods for detecting malaria - the broader perspective.
    Clin Infect Dis. 2021 Mar 9. pii: 6164943. doi: 10.1093.
    >> Share

  34. NIANG M, Sandfort M, Mbodj AF, Diouf B, et al
    Fine-scale spatio-temporal mapping of asymptomatic and clinical P. falciparum infections: epidemiological evidence for targeted malaria elimination interventions.
    Clin Infect Dis. 2021 Mar 2. pii: 6157008. doi: 10.1093.
    >> Share

    February 2021
  35. KITABI E, Bensman TJ, Earp JC, Chilukuri DM, et al
    Effect of Body Weight and Age on the Pharmacokinetics of Dihydroartemisinin: FDA Basis for Dose Determination of Artesunate for Injection in Pediatric Patients with Severe Malaria.
    Clin Infect Dis. 2021 Feb 19. pii: 6144983. doi: 10.1093.
    >> Share

  36. ROUSSEL C, Ndour PA, Kendjo E, Larreche S, et al
    Intravenous artesunate for the treatment of severe imported malaria: implementation, efficacy and safety in 1391 patients.
    Clin Infect Dis. 2021 Feb 13. pii: 6134777. doi: 10.1093.
    >> Share

  37. GILLETTE MA, Mani DR, Uschnig C, Pelle KG, et al
    Biomarkers to distinguish bacterial from viral pediatric clinical pneumonia in a malaria endemic setting.
    Clin Infect Dis. 2021 Feb 3. pii: 6127315. doi: 10.1093/cid/ciaa1843.
    >> Share

  38. AUNG NM, Nyein PP, Kyi MM, Hanson J, et al
    Bacterial Coinfection in Adults With Severe Malaria.
    Clin Infect Dis. 2021;72:535-536.
    >> Share

  39. WHITE NJ
    Reply to Aung et al.
    Clin Infect Dis. 2021;72:536-538.
    >> Share

    January 2021
  40. MISCHLINGER J, Dudek V, Ramharter M
    Predictive performance of rapid diagnostic tests for falciparum malaria and its modelled impact on integrated community case management of malaria in sub-Saharan African febrile children.
    Clin Infect Dis. 2021 Jan 28. pii: 6121687. doi: 10.1093/cid/ciaa1942.
    >> Share

  41. PHIRI MD, Cairns M, Zongo I, Nikiema F, et al
    The duration of protection from azithromycin against malaria, acute respiratory, gastro-intestinal and skin infections when given alongside seasonal malaria chemoprevention: secondary analyses of data from a clinical trial in Hounde, Burkina Faso and
    Clin Infect Dis. 2021 Jan 8. pii: 6071007. doi: 10.1093/cid/ciaa1905.
    >> Share

  42. PETERSEN E, Grobusch MP
    Accurate malaria diagnosis: not only essential for malaria case management, but prerequisite for managing febrile disease in the tropics.
    Clin Infect Dis. 2021 Jan 4. pii: 6062465. doi: 10.1093/cid/ciaa1945.
    >> Share

    December 2020
  43. SAHU PK, Hoffmann A, Majhi M, Pattnaik R, et al
    Brain Magnetic Resonance Imaging Reveals Different Courses of Disease in Pediatric and Adult Cerebral Malaria.
    Clin Infect Dis. 2020 Dec 16. pii: 6035083. doi: 10.1093/cid/ciaa1647.
    >> Share

  44. JOHN CC
    Adults Are Not Big Children: What Brain Magnetic Resonance Imaging Findings Tell Us About Differences in Pediatric and Adult Cerebral Malaria.
    Clin Infect Dis. 2020 Dec 16. pii: 6035081. doi: 10.1093/cid/ciaa1659.
    >> Share

    November 2020
  45. MITCHELL CL, Topazian HM, Brazeau NF, Deutsch-Feldman M, et al
    Household prevalence of P. falciparum, P. vivax, and P. ovale in the Democratic Republic of the Congo, 2013-2014.
    Clin Infect Dis. 2020 Nov 26. pii: 6006303. doi: 10.1093/cid/ciaa1772.
    >> Share

    September 2020
  46. BERMAN JD
    Treating Severe Malaria.
    Clin Infect Dis. 2020 Sep 30. pii: 5913352. doi: 10.1093.
    >> Share

  47. LYKE KE, Singer A, Berry AA, Reyes S, et al
    Multidose Priming and Delayed Boosting Improve PfSPZ Vaccine Efficacy against Heterologous P. falciparum Controlled Human Malaria Infection.
    Clin Infect Dis. 2020 Sep 12. pii: 5904973. doi: 10.1093/cid/ciaa1294.
    >> Share

  48. HOUNKONNOU CPA, Ndam NT, Fievet N, Accrombessi M, et al
    Sub-optimal Intermittent Preventive Treatment in pregnancy (IPTp) is associated with an increased risk of submicroscopic P. falciparum infection in pregnant women: a prospective cohort study in Benin.
    Clin Infect Dis. 2020 Sep 9. pii: 5903262. doi: 10.1093/cid/ciaa1355.
    >> Share

    August 2020
  49. UYOGA S, Wanjiku P, Rop JC, Makale J, et al
    Plasma Plasmodium falciparum Histidine-Rich Protein-2 concentrations in children with malaria infections of differing severity in Kilifi, Kenya.
    Clin Infect Dis. 2020 Aug 9. pii: 5890098. doi: 10.1093/cid/ciaa1141.
    >> Share

    July 2020
  50. YANG H, Wang J, Liu H, Zhao Y, et al
    Efficacy and Safety of a Naphthoquine-Azithromycin Co-Formulation for Malaria Prophylaxis in Southeast Asia: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial.
    Clin Infect Dis. 2020 Jul 20. pii: 5873746. doi: 10.1093/cid/ciaa1018.
    >> Share

  51. KUBLIN JG, Murphy SC, Maenza J, Seilie AM, et al
    Safety, pharmacokinetics and causal prophylactic efficacy of KAF156 in a Plasmodium falciparum human infection study.
    Clin Infect Dis. 2020 Jul 9. pii: 5869402. doi: 10.1093.
    >> Share

    June 2020
  52. JAFARI-GUEMOURI S, Courtois L, Mama A, Rouas B, et al
    A genotypical study in Benin comparing the carriage of P. falciparum infections before pregnancy and in the early pregnancy: story of a persistent infection.
    Clin Infect Dis. 2020 Jun 22. pii: 5860917. doi: 10.1093.
    >> Share

  53. SAMUELS AM, Odero NA, Odongo W, Otieno K, et al
    Response to Hamer and Millers' Commentary, "Why did mass test and treat have no effect on malaria prevalence in western Kenya?"
    Clin Infect Dis. 2020 Jun 21. pii: 5860454. doi: 10.1093.
    >> Share

  54. WHITE NJ
    Bacteremia in adults with severe malaria.
    Clin Infect Dis. 2020 Jun 7. pii: 5854310. doi: 10.1093.
    >> Share

  55. BUNDI CK, Nalwoga A, Lubyayi L, Muriuki JM, et al
    Iron deficiency is associated with reduced levels of Plasmodium falciparum-specific antibodies in African children.
    Clin Infect Dis. 2020 Jun 7. pii: 5854375. doi: 10.1093.
    >> Share

  56. AUNG NM, Nyein PP, Kyi MM, Hanson J, et al
    Bacterial co-infection in adults with severe malaria.
    Clin Infect Dis. 2020 Jun 6. pii: 5854309. doi: 10.1093.
    >> Share

    May 2020
  57. PETERSEN E, Picot S
    The end of the artemisinin era - - we should aim at malaria eradication in Asia using free effective treatment.
    Clin Infect Dis. 2020 May 27. pii: 5847809. doi: 10.1093.
    >> Share

  58. MAIRET-KHEDIM M, Leang R, Marmai C, Khim N, et al
    Clinical and in vitro resistance of Plasmodium falciparum to artesunate-amodiaquine in Cambodia.
    Clin Infect Dis. 2020 May 27. pii: 5847731. doi: 10.1093.
    >> Share

  59. OPOKA RO, Waiswa A, Harriet N, John CC, et al
    Blackwater Fever in Ugandan Children With Severe Anemia is Associated With Poor Postdischarge Outcomes: A Prospective Cohort Study.
    Clin Infect Dis. 2020;70:2247-2254.
    >> Share

    April 2020
  60. HAMER DH, Miller JM
    Why did mass test and treat have no effect on malaria prevalence in western Kenya?
    Clin Infect Dis. 2020 Apr 23. pii: 5824322. doi: 10.1093.
    >> Share

  61. SAMUELS AM, Odero NA, Odongo W, Otieno K, et al
    Impact of community-based mass testing and treatment on malaria infection prevalence in a high transmission area of western Kenya: A cluster randomized controlled trial.
    Clin Infect Dis. 2020 Apr 23. pii: 5824323. doi: 10.1093.
    >> Share

    February 2020
  62. PHU NH, Day NPJ, Tuan PQ, Mai NTH, et al
    Concomitant bacteremia in adults with severe falciparum malaria.
    Clin Infect Dis. 2020 Feb 28. pii: 5763096. doi: 10.1093.
    >> Share

    January 2020
  63. FROSCH AEP
    Artesunate Versus Quinine: Keeping Our Options Open.
    Clin Infect Dis. 2020;70:288-289.
    >> Share

    November 2019
  64. JONGO SA, Church LWP, Mtoro AT, Chakravarty S, et al
    Increase of dose associated with decrease in protection against controlled human malaria infection by PfSPZ Vaccine in Tanzanian adults.
    Clin Infect Dis. 2019 Nov 29. pii: 5647428. doi: 10.1093/cid/ciz1152.
    >> Share

    October 2019
  65. HEALY SA, Murphy SC, Hume JCC, Shelton L, et al
    Chemoprophylaxis vaccination: Phase 1 study to explore stage-specific immunity to Plasmodium falciparum in U.S. adults.
    Clin Infect Dis. 2019 Oct 17. pii: 5588862. doi: 10.1093/cid/ciz1010.
    >> Share

  66. LI K, Xu Y, Liu L, Wu J, et al
    Malaria among UN peacekeepers in The Democratic Republic of the Congo, South Kivu areas, Jan 2016-Jul 2019.
    Clin Infect Dis. 2019 Oct 9. pii: 5584329. doi: 10.1093.
    >> Share

    September 2019
  67. STEINHARDT LC, Richie TL, Yego R, Akach D, et al
    Safety, tolerability, and immunogenicity of PfSPZ Vaccine administered by direct venous inoculation to infants and young children: findings from an age de-escalation, dose-escalation double-blinded randomized, controlled study in western Kenya.
    Clin Infect Dis. 2019 Sep 26. pii: 5573993. doi: 10.1093.
    >> Share

  68. HOUNKONNOU CPA, Briand V, Fievet N, Accrombessi M, et al
    Dynamics of Submicroscopic Plasmodium falciparum Infections Throughout Pregnancy: A Preconception Cohort Study in Benin.
    Clin Infect Dis. 2019 Sep 12. pii: 5563807. doi: 10.1093.
    >> Share

    February 2019
  69. AWANDU SS, Raman J, Bousema T, Birkholtz LM, et al
    Ultra-low-density Plasmodium falciparum infections in African settings.
    Clin Infect Dis. 2019 Feb 15. pii: 5320191. doi: 10.1093.
    >> Share

  70. BRADLEY J, Soumare HM, Mahamar A, Diawara H, et al
    Transmission-blocking effects of primaquine and methylene blue suggest P. falciparum gametocyte sterilisation rather than effects on sex ratio.
    Clin Infect Dis. 2019 Feb 12. pii: 5316265. doi: 10.1093.
    >> Share

    November 2018
  71. MCCARTHY JS, Smith B, Reid M, Berman J, et al
    Blood schizonticidal activity and safety of tafenoquine when administered as chemoprophylaxis to healthy, non-immune participants followed by blood stage Plasmodium falciparum challenge: A randomized, double-blinded, placebo-controlled Phase 1b study.
    Clin Infect Dis. 2018 Nov 1. pii: 5154907. doi: 10.1093.
    >> Share

    May 2018
  72. IPPOLITO MM, Jacobson JM, Lederman MM, Winterberg M, et al
    Effect of antiretroviral therapy on plasma concentrations of chloroquine and desethyl-chloroquine.
    Clin Infect Dis. 2018 May 16. pii: 4996547. doi: 10.1093.
    >> Share

  73. BUCHWALD AG, Sixpence A, Chimenya M, Damson M, et al
    Clinical implications of asymptomatic Plasmodium falciparum infections in Malawi.
    Clin Infect Dis. 2018 May 16. pii: 4996917. doi: 10.1093.
    >> Share

    March 2018
  74. GALATAS B, Marti-Soler H, Nhamussua L, Cistero P, et al
    Dynamics of afebrile Plasmodium falciparum Infections in Mozambican Men.
    Clin Infect Dis. 2018 Mar 13. pii: 4931589. doi: 10.1093.
    >> Share

    January 2018
  75. ROSSI G, Vernaeve L, Van den Bergh R, Nguon C, et al
    Closing in on the Reservoir: Proactive Case Detection in High-Risk Groups as a Strategy to Detect Plasmodium falciparum Asymptomatic Carriers in Cambodia.
    Clin Infect Dis. 2018 Jan 18. pii: 4816713. doi: 10.1093/cid/cix1064.
    >> Share

  76. TADESSE FG, Slater HC, Chali W, Teelen K, et al
    The relative contribution of symptomatic and asymptomatic Plasmodium vivax and Plasmodium falciparum infections to the infectious reservoir in a low-endemic setting in Ethiopia.
    Clin Infect Dis. 2018 Jan 3. pii: 4786592. doi: 10.1093/cid/cix1123.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016